134 related articles for article (PubMed ID: 7847228)
21. [Valproate-induced hyperammonemic encephalopathy].
Diaz-Rangel M; Grande-Martin A; Monsalve-Naharro JA; Domingo-Chiva E; Cuesta-Montero P; Lopez-Perez A
Rev Neurol; 2017 Dec; 65(12):574-575. PubMed ID: 29235622
[TBL] [Abstract][Full Text] [Related]
22. Valproate acute administration, EEG epileptic abnormalities, and ammonemia.
Sannita WG
Neurology; 1992 Oct; 42(10):2003-5. PubMed ID: 1407583
[TBL] [Abstract][Full Text] [Related]
23. Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient.
Kulick SK; Kramer DA
Ann Emerg Med; 1993 Mar; 22(3):610-2. PubMed ID: 8192712
[TBL] [Abstract][Full Text] [Related]
24. A case of valproate-induced encephalopathy.
Hong L; Schutz J; Nance M
Aust N Z J Psychiatry; 2012 Dec; 46(12):1200-1. PubMed ID: 22619383
[No Abstract] [Full Text] [Related]
25. [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy].
Rottach KG; Weiss-Brummer J; Wieland U; Schmauss M
Nervenarzt; 2000 May; 71(5):401-3. PubMed ID: 10846716
[TBL] [Abstract][Full Text] [Related]
26. Valproate-induced hyperammonemic encephalopathy: imaging findings on diffusion-weighted MRI.
Grubben B; De Jonghe P; Cras P; Demey HE; Parizel PM
Eur Neurol; 2004; 52(3):178-81. PubMed ID: 15528922
[No Abstract] [Full Text] [Related]
27. Valproic acid-induced hyperammonemia: a case report.
McCall M; Bourgeois JA
J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
[TBL] [Abstract][Full Text] [Related]
28. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
[TBL] [Abstract][Full Text] [Related]
29. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
Toksoy HB; Tanzer FN; Atalay A
Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
[TBL] [Abstract][Full Text] [Related]
30. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
[TBL] [Abstract][Full Text] [Related]
31. The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?
Chicharro AV; de Marinis AJ; Kanner AM
Epilepsy Behav; 2007 Nov; 11(3):361-6. PubMed ID: 17845866
[TBL] [Abstract][Full Text] [Related]
32. Adaptation of hepatic ammonia metabolism after chronic valproate administration in epileptics treated with phenytoin.
Marescaux C; Warter JM; Brandt C; Rumbach L; Micheletti G; Chabrier G; Imler M
Eur Neurol; 1985; 24(3):191-5. PubMed ID: 3922765
[TBL] [Abstract][Full Text] [Related]
33. [A case report of valproate encephalopathy].
Miyamoto T; Miyamoto M; Hirata K; Katayama S
Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
[TBL] [Abstract][Full Text] [Related]
34. Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid.
Iinuma K; Hayasaka K; Narisawa K; Tada K; Hori K
Eur J Pediatr; 1988 Dec; 148(3):267-9. PubMed ID: 3145882
[TBL] [Abstract][Full Text] [Related]
35. Exercises in clinical reasoning: a confusing interaction.
Shah UA; Henderson MC; Abourjaily P; Thaler D; Rencic J
J Gen Intern Med; 2015 Jun; 30(6):860-3. PubMed ID: 25623299
[No Abstract] [Full Text] [Related]
36. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
Coulter DL; Allen RJ
Lancet; 1980 Jun; 1(8181):1310-1. PubMed ID: 6104123
[No Abstract] [Full Text] [Related]
37. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.
Verrotti A; Greco R; Morgese G; Chiarelli F
Int J Clin Lab Res; 1999; 29(1):36-40. PubMed ID: 10356662
[TBL] [Abstract][Full Text] [Related]
38. Triphasic waves associated with acute naproxen overdose: a case report.
Bortone E; Bettoni L; Buzio S; Giorgi C; Melli G; Mineo F; Mancia D
Clin Electroencephalogr; 1998 Jul; 29(3):142-5. PubMed ID: 9660016
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma.
Hantson P; Grandin C; Duprez T; Nassogne MC; Guérit JM
Eur Radiol; 2005 Jan; 15(1):59-64. PubMed ID: 15647953
[TBL] [Abstract][Full Text] [Related]
40. [Encephalopathies caused by valproate].
Göbel R; Görtzen A; Bräunig P
Fortschr Neurol Psychiatr; 1999 Jan; 67(1):7-11. PubMed ID: 10065384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
